Small caps round-up: Ark Therapeutics, Volex, GoIndustry
Also includes: Blinkx
Medical company Ark Therapeutics said a consortium led by University College London, in which the company was the sole industrial partner engaged in research, was to receive €6m from the EU. The grant would enable Ark's gene-therapy programme in foetal growth restriction to enter into clinical development, it said. Its shares rose 7.4% on the news.
Volex, a provider of electrical, digital and optical connections, said it had appointed David McKinney to the newly created position of Chief Operating Officer (COO). McKinney most recently served as COO of broadcast technology firm Pace from November 2005 to January 2012. The firm said it hoped the new hire would help drive "substantial, sustainable and profitable growth of the company".
Try 6 free issues of MoneyWeek today
Get unparalleled financial insight, analysis and expert opinion you can profit from.
Sign up for MoneyWeek’s free twice-daily newsletter.
Join more than 165,000 subscribers and keep yourself informed with latest financial news, insights and expert analysis to help you understand what really matters when it comes to your finances.
Join more than 165,000 subscribers and keep yourself informed with latest financial news, insights and expert analysis to help you understand what really matters when it comes to your finances.
